Skip to main content

Table 1 Characteristics of 25 children with pediatric rheumatic diseases treated with Adalimumab.

From: PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience

AAA Girls JIA ANA+ Uveitis Active uveitis Active
arthritis
MTX Drug switching
Present
n = 8
6 (75) 4 (50) 4 (50) 8 (100) 6 (75) 2 (25) 2 (25) 4 (50)
Absent
n = 17
13 (77) 15 (88) 6 (35) 13 (77) 3 (18) 5 (29) 6 (35) 4 (24)
  1. Data are expressed as n (%)
  2. AAA = Antiadalimumab antibodies; JIA = Juvenile Idiopathic Arthritis; ANA = Antinuclear antibodies; MTX = Concomitant Methotrexate.